Cellectar Biosciences Files 2024 Annual Report
Ticker: CLRB · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 10-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Cellectar Bio filed its 2024 10-K. Check financials.
AI Summary
Cellectar Biosciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as NOVELOS THERAPEUTICS, INC., is in the pharmaceutical preparations industry. The filing details financial information and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Cellectar Biosciences' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cellectar Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The report covers the period ending December 31, 2024.)
- 2025-03-13 — Filing Date (The 10-K was filed on March 13, 2025.)
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Filer
- NOVELOS THERAPEUTICS, INC. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-13 (date) — Filing date
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932 (address) — Business and mail address
FAQ
What is the primary business of Cellectar Biosciences, Inc.?
Cellectar Biosciences, Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
When did Cellectar Biosciences, Inc. change its name from NOVELOS THERAPEUTICS, INC.?
The company changed its name from NOVELOS THERAPEUTICS, INC. on June 17, 2005.
What is the business address of Cellectar Biosciences, Inc.?
The business address is 100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
What is the SEC file number for Cellectar Biosciences, Inc.?
The SEC file number for Cellectar Biosciences, Inc. is 001-36598.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Cellectar Biosciences, Inc. (CLRB).